MSSP ACO Public Reporting
ACO Name and Location
Genovista Health, LLC
Previous Names: Genesis Physicians Group, Inc.
5501 LBJ Freeway
Suite 950
Dallas, TX 75240
ACO Primary Contact
Name
Ashley NelsonPhone
972.419.0012Email
Ashley.Nelson@genesisdocs.org
Organizational Information
| ACO Participants | ACO Participant in Joint Venture |
|---|---|
| 360 CLINICS PLLC | N |
| AB Internal Medicine Group PA | N |
| Allen Children's Clinic, PA | N |
| Aruna Koney, MD.,PA | N |
| BRYAN G. JOHNSON MD, PA | N |
| CHERRY CHANDI, M.D., P.A. | N |
| CHIJIOKE D. UKOHA MD PA | N |
| CHUKWUMA OSUAGWU MD PA | N |
| CORINTHIA MCLEROY, MD PA | N |
| DAPHNE L FAVROTH MD AND ASSOCIATES | N |
| DAVID F. CORRAL, M.D., P.A. | N |
| Dennis Dinh Tran M.D.,PA. | N |
| DOCTOR IS IN, PA | N |
| Dr. Matthew Thompson Pllc | N |
| FAMILY CENTER VITALEHEALTH, PLLC | N |
| FIROZ MEDICAL GROUP, PA | N |
| FLESCHLER & PHILLIPS MEDICAL GROUP LLC | N |
| Forest Lane Family Medicine, PA | N |
| GARY E GOFF MD PA | N |
| HIGHLAND VILLAGE PRIMARY CARE, P.A. | N |
| Irwin S. Korngut Mdpa | N |
| JAMES E RACE MD PA | N |
| JIRCIK MEDICAL GROUP | N |
| Jocelyn B Dunham, MD, PA | N |
| Kare Family Clinic | N |
| KELSOM CLINIC PA | N |
| Kenneth E. Baird, M.D., P.A. | N |
| LISA CLARK | N |
| LIVINGSPRING FAMILY MEDICAL CENTER PLLC | N |
| LIVINGSTON MEDICAL PLLC | N |
| Love Wounds | N |
| MAINMEDPLUS PLLC | N |
| MELROSE CLINIC PLLC | N |
| METROPLEX CARE GROUP | N |
| North Texas Hospital Physicians Group | N |
| PHILLIP M. ARONOFF, M.D., P.A. | N |
| PREMIER FAMILY MEDICAL, PA | N |
| PRUNA FAMILY MEDICINE PLLC | N |
| QUESTCARE MEDICAL CLINICS PLLC | N |
| RAKESH SAINI | N |
| Randall Hayes | N |
| RUFINO G. TALATALA, M.D., P.A. | N |
| RUSHING FAMILY PRACTICE | N |
| SCOTT NEUMANN DO PA | N |
| SINSOTE MEDICAL CARE PLLC | N |
| VITAL CARE CLINIC, LLC | N |
| YZ HEALTHCARE PA | N |
ACO Governing Body
| Member Last Name | Member First Name | Member Title / Position | Member's Voting Power (Expressed as a % or #) | Membership Type | ACO Participant Legal Business Name / DBA (if applicable) |
|---|---|---|---|---|---|
| Korngut | Irwin | Chairman Voting Member | 1 | ACO Participant Representative | Irwin S. Korngut Mdpa |
| Baird | Kenneth | Voting Member | 1 | ACO Participant Representative | Kenneth E. Baird, M.D., P.A. |
| Talatala | Rufino | Voting Member | 1 | ACO Participant Representative | RUFINO G. TALATALA, M.D., P.A. |
| Dunham | Jocelyn | Voting Member | 1 | ACO Participant Representative | Jocelyn B Dunham, MD, PA |
| Opalach | Matthew | Voting Member | 1 | ACO Participant Representative | QUESTCARE MEDICAL CLINICS PLLC |
| Boysselle | Skylar | Voting Member | 1 | Medicare Beneficiary Representative | NA |
Associated Committees and Committee Leadership
Committee Name | Committee Leader Name and Position |
|---|---|
Quality Improvement Committee | Anna Tseng MD, Chair |
IT / Compliance Committee | Charles Dunlap MD, Chair |
Membership Committee | Scott Yates MD, Chair |
Finance Committee | John Tan MD, Chair |
Key ACO Clinical and Administrative Leadership
James Walton
ACO ExecutiveAnna Tseng
Medical DirectorJessica Johnson
Compliance OfficerAnna Tseng
Quality Assurance / Improvement Officer
Types of ACO participants, or combinations of participants, that formed the ACO:
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- First Agreement Period
- Performance Year 2018, $1,705,464
- Performance Year 2019, $1,195,336
- Performance Year 2020, $4,182,206
Shared Savings Distribution
- First Agreement Period
- Performance Year 2018
- Proportion invested in infrastructure: 23%
- Proportion invested in redesigned care processes/resources: 44%
- Proportion of distribution to ACO participants: 33%
- Performance Year 2019
- Proportion invested in infrastructure: 23%
- Proportion invested in redesigned care processes/resources: 44%
- Proportion of distribution to ACO participants: 33%
- Performance Year 2020
- Proportion invested in infrastructure: 23%
- Proportion invested in redesigned care processes/resources: 44%
- Proportion of distribution to ACO participants: 33%
- Performance Year 2018
Quality Performance Results
2020 Quality Performance Results:
| ACO# | Measure Name | Rate | ACO Mean |
|---|---|---|---|
| ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) | 1.19 | 0.95 |
| ACO-13 | Falls: Screening for Future Fall Risk | 88.76 | 84.97 |
| ACO-14 | Preventive Care and Screening: Influenza Immunization | 55.63 | 76.03 |
| ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 64.86 | 81.67 |
| ACO-18 | Preventive Care and Screening: Screening for Depression and Follow-up Plan | 51.74 | 71.46 |
| ACO-19 | Colorectal Cancer Screening | 71.95 | 72.59 |
| ACO-20 | Breast Cancer Screening | 66.45 | 74.05 |
| ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 89.04 | 83.37 |
| ACO-27 | Diabetes: Hemoglobin A1c Poor Control (>9%) | 9.76 | 14.70 |
| ACO-28 | Controlling High Blood Pressure | 74.45 | 72.87 |
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
Payment Rule Waivers
- Skilled Nursing Facility (SNF) 3-day Rule Waiver:
- Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.